[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 13 sources · 2 days · First seen · Last updated

Hanmi Pharmaceutical obesity drug development

Overview

Hanmi Pharmaceutical is advancing its obesity and metabolic disease drug pipeline through both international licensing and domestic development.

In late August 2026, Hanmi entered an exclusive licensing agreement with Genentech, a subsidiary of the Roche Group, valued at up to $2.3 billion. The deal covers the drug candidate HM17321, a non-incretin Urocortin-2 (UCN2) analog designed to target obesity, type 2 diabetes, and cardiovascular diseases. Genentech will hold exclusive rights to develop and commercialize the candidate globally, excluding South Korea, once Hanmi completes ongoing Phase 1 clinical trials.

Concurrently, Hanmi is preparing for the release of ‘Epe’ (efpeglenatide), South Korea’s first domestic GLP-1 obesity drug, scheduled for the second half of 2026. To chronicle the development of this drug, the company is producing a documentary titled ‘H. O. P (Hanmi Obesity Pipeline)’. The film will detail how Hanmi utilized its proprietary ‘LAPSCOVERY’ platform to continue development after rights were returned following a change in a global partner’s business strategy.

Entities

Hanmi Pharmaceutical · HM17321 · Hanmi Science · Roche Group · South Korea

Timeline

  1. 22 days ago

    [BUSINESS] 2 sources
    Hanmi Pharmaceutical to produce documentary on obesity drug Epe

    Hanmi Pharmaceutical is producing a documentary about the development of ‘Epe’, South Korea’s first domestic GLP-1 obesity drug, slated for release later this year.

  2. 24 days ago

    [BUSINESS] 13 sources
    Hanmi Pharmaceutical signs $2.3 billion obesity drug deal with Genentech

    Hanmi Pharmaceutical signed a deal worth up to $2.3 billion with Genentech to license its obesity drug candidate HM17321, which aims to reduce weight while preserving muscle mass.

Sources

ad-hoc-news.de · biz.heraldcorp.com · bosa.co.kr · healthcaremea.com · koreaherald.com · m.imaeil.com · newstomato.com · seoul.co.kr · socialvalue.kr · thebionews.net · tokenpost.kr · xconomy.com · zdnet.co.kr